Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Mallinckrodt
Johnson and Johnson
McKesson
Boehringer Ingelheim

Last Updated: January 22, 2020

DrugPatentWatch Database Preview

Litigation Details for Alvogen Pine Brook LLC v. Noven Pharmaceuticals, Inc. (D. Del. 2016)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Alvogen Pine Brook LLC v. Noven Pharmaceuticals, Inc. (D. Del. 2016)

Docket   Start Trial Date Filed 2016-05-27
Court District Court, D. Delaware Date Terminated 2016-11-07
Cause 35:145 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties ALVOGEN PINE BROOK LLC; HISAMITSU PHARMACEUTICAL CO., INC.; NOVEN PHARMACEUTICALS, INC.
Patents 6,841,716; 8,231,906
Attorneys Dominick T. Gattuso; Stephen J. Kraftschik
Firms Heyman Enerio Gattuso & Hirzel LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Alvogen Pine Brook LLC v. Noven Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Alvogen Pine Brook LLC v. Noven Pharmaceuticals, Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-05-27 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,841,716; 8,231,906;. (sar) …2016 7 November 2016 1:16-cv-00395 830 Patent None District Court, D. Delaware External link to document
2016-11-07 9 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,841,716; 8,231,906. (ntl) (…2016 7 November 2016 1:16-cv-00395 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Boehringer Ingelheim
Baxter
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.